Experimental models of Huntington's disease

被引:9
|
作者
Garcia-Ramos, R.
del Val-Fernandez, J.
Catalan-Alonso, M. J.
Barcia-Albacar, J. A.
Matias-Guiu, J.
机构
[1] Hosp Clin San Carlos, Unidad Trastornos Movimiento, E-28040 Madrid, Spain
[2] Hosp Clin San Carlos, Serv Neurocirugia, E-28040 Madrid, Spain
[3] Hosp Clin San Carlos, Inst Neurociencias, E-28040 Madrid, Spain
关键词
3-nitropropionic acid; cellular models; excitotoxic models; Huntington's disease; quinolinic acid; Transgenic mice;
D O I
10.33588/rn.4507.2007238
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Huntington's disease (HD) is an autosomal dominant hereditary disease caused by triplet repetition in exon I of the huntingtin protein located in chromosome 4. Medium spiny neurons in the striatum are selectively affected. Clinical manifestations include progressive behavioural, motor and cognitive disorders. There is no treatment available today capable of modifying the natural course of the disease. A great amount of research work is being carried out, much of which involves animal models of the disease. Development. We reviewed the articles published in PubMed on basic research into HD and analysed the most frequently used models. Transgenic mouse models, excitotoxic models, transgenic fly models and cell cultures are all used in studies into HD. The advantages and disadvantages of each of them are highlighted. Conclusion. The contribution made by each model of HD must be known in order to draw up a correct design in experimental studies of the disease. [REV NEUROL 2007; 45: 437-41]
引用
收藏
页码:437 / 441
页数:5
相关论文
共 50 条
  • [41] Huntington's Disease: Calcium Dyshomeostasis and Pathology Models
    Kolobkova, Y. A.
    Vigont, V. A.
    Shalygin, A. V.
    Kaznacheyeva, E. V.
    ACTA NATURAE, 2017, 9 (02): : 34 - 46
  • [42] Large Genetic Animal Models of Huntington's Disease
    Morton, A. Jennifer
    Howland, David S.
    JOURNAL OF HUNTINGTONS DISEASE, 2013, 2 (01) : 3 - 19
  • [43] Large animal models for Huntington's disease research
    Han, Bofeng
    Liang, Weien
    Li, Xiao-Jiang
    Li, Shihua
    Yan, Sen
    Tu, Zhuchi
    ZOOLOGICAL RESEARCH, 2024, 45 (02) : 275 - 283
  • [44] Advances in Huntington's disease: Implications for experimental therapeutics
    Feigin, A
    CURRENT OPINION IN NEUROLOGY, 1998, 11 (04) : 357 - 362
  • [45] Replicating Huntington's disease phenotype in experimental animals
    Brouillet, E
    Condé, F
    Beal, MF
    Hantraye, P
    PROGRESS IN NEUROBIOLOGY, 1999, 59 (05) : 427 - 468
  • [46] Cytotoxicity models of Huntington's disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies
    Calabrese, Edward J.
    Bhatia, Tarun N.
    Calabrese, Vittorio
    Dhawan, Gaurav
    Giordano, James
    Hanekamp, Yannic N.
    Kapoor, Rachna
    Kozumbo, Walter J.
    Leak, Rehana K.
    PHARMACOLOGICAL RESEARCH, 2019, 150
  • [47] Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
    Diguet, E
    Fernagut, PO
    Wei, X
    Du, YS
    Rouland, R
    Gross, C
    Bezard, E
    Tison, F
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (12) : 3266 - 3276
  • [48] Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
    Diguet, E
    Fernagut, PO
    Wei, X
    Du, Y
    Bezard, E
    Tison, F
    MOVEMENT DISORDERS, 2004, 19 : S388 - S388
  • [49] Huntington's disease: Neuropsychiatric manifestations of Huntington's disease
    Goh, Anita M. Y.
    Wibawa, Pierre
    Loi, Samantha M.
    Walterfang, Mark
    Velakoulis, Dennis
    Looi, Jeffrey C. L.
    AUSTRALASIAN PSYCHIATRY, 2018, 26 (04) : 366 - 375
  • [50] Stuck in the Middle: Huntington's Disease or not Huntington's Disease?
    Ziso, Besa
    Larner, Andrew J.
    Alusi, Sundus H.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 27 (01) : E85 - E86